Edmund Dunn

Insider Reports History

Location
Boston, MA
Signature
/s/ Markus Warmuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edmund Dunn:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Principal Accounting Officer Common Stock 22,693 $344,252 $15.17 05 Jan 2026 Direct
Monte Rosa Therapeutics, Inc. Principal Accounting Officer Stock Option (Right to Buy) 53,400 02 Jan 2025 Direct

Insider Reports Filed by Edmund Dunn

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLUE Monte Rosa Therapeutics, Inc. 05 Jan 2026 1 -$15,762 4 Principal Accounting Officer 05 Jan 2026, 16:04
GLUE Monte Rosa Therapeutics, Inc. 03 Jun 2025 1 -$9,174 4 Principal Accounting Officer 04 Jun 2025, 16:15
GLUE Monte Rosa Therapeutics, Inc. 02 Jan 2025 2 $0 4 Principal Accounting Officer 06 Jan 2025, 16:15
GLUE Monte Rosa Therapeutics, Inc. 05 Jul 2024 1 -$6,166 4 Principal Accounting Officer 09 Jul 2024, 16:15
GLUE Monte Rosa Therapeutics, Inc. 03 Jun 2024 1 -$4,876 4 Principal Accounting Officer 05 Jun 2024, 16:10
GLUE Monte Rosa Therapeutics, Inc. 02 Jan 2024 2 $0 4 Principal Accounting Officer 04 Jan 2024, 16:15
GLUE Monte Rosa Therapeutics, Inc. 08 Aug 2023 0 $0 3 Principal Accounting Officer 18 Aug 2023, 16:00